Results 151 to 160 of about 28,778 (201)

Disruption of CDK5 regulatory subunit 1, p35, limits immunosuppressive M2 macrophages while maintaining functional M1 macrophages. [PDF]

Front Immunol
Zampieri JR, Choi SH, Myers JT, Tomchuck SL, Eid S, Askew D, Huang AY.   +6 more
europepmc   +1 more source

Tauopathies: Calmodulin Regulates Tau Hyperphosphorylation and Its Transformation into Disease-Specific Aggregates. [PDF]

Biomolecules
O'Day DH.
europepmc   +1 more source

Pathological Calcium Signaling in Traumatic Brain Injury and Alzheimer's Disease: From Acute Neuronal Injury to Chronic Neurodegeneration. [PDF]

Int J Mol Sci
Neuschmid S, Schallerer C, Ehrlich BE, McGuone D.   +3 more
europepmc   +1 more source

LIMK1 as a Novel Kinase of β-Catenin Promotes Esophageal Cancer Metastasis by Cooperating With CDK5. [PDF]

Adv Sci (Weinh)
Li SJ, Liang ZR, Liu ZC, Luo XP, Li JY, Yu XM, Huang XZ, He Y, Xu TY, Xu JJ, Peng SC, Song YX, He Y, Zhuang XW, Zheng CC, Zhang F, Lam AK, Dai W, He ML, Liu B, Zhao Q, Lu GL, Liu JB, Wang ZN, Li ZG, Liu ZX, Xu WW, Li B.   +27 more
europepmc   +1 more source

BSCL2 and CDK5 are two genes associated with circadian rhythm disturbance in Parkinson's disease. [PDF]

Sci Rep
Chen D, Huang Q, Ye M.
europepmc   +1 more source

CDK5 targets p21^CIP1 to regulate thyroid cancer cell proliferation and malignancy in patients. [PDF]

Mol Med Rep
Tung MC, Oner M, Soong SW, Cheng PT, Li YH, Chen MC, Chou CK, Kang HY, Lin FC, Tsai SC, Lin H.   +10 more
europepmc   +1 more source

A new pathway for neuroprotection against tau hyperphosphorylation via δ-opioid receptor initiated inhibition of CDK5 and AMPK signaling. [PDF]

Front Aging Neurosci
Li J, Xu Y, Balboni G, Xia Y.
europepmc   +1 more source

Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. <i>Cancers</i> 2020, <i>12</i>, 1935. [PDF]

Cancers (Basel)
Tabouret E, Wang H, Amin N, Jung J, Appay R, Cui J, Song Q, Cardone A, Park DM, Gilbert MR, Pant H, Zhuang Z.   +11 more
europepmc   +1 more source

ATG9B-4 accelerates the proliferation and migration of liver cancer cells in an ARNTL-CDK5 pathway-dependent manner: A case-control study. [PDF]

Medicine (Baltimore)
Li M, Tang J, Zhu W, Cheng C, Guo L, Liu P, Mo Z.   +6 more
europepmc   +1 more source

From silico to benchtop: cosmosiin as a PD-1/PDL-1 immune checkpoint inhibitor revealed through DFT, network pharmacology analysis, and molecular docking integrated experimental verification. [PDF]

RSC Adv
Alsantali RI, Almohyawi AM, Rather MA, Mir JM, Dangroo NA, Almalki FA, Ben Hadda T, Jassas RS, Alkubaysi SI, Ahmed SA.   +9 more
europepmc   +1 more source